The global diabetes care devices market is expected to reach USD 64.5 billion in 2024. The sales are expected to grow even higher and will be estimated at USD 117.7 billion in 2034 due to the rising diabetes population. The diabetes care devices market is anticipated to record a CAGR of 6.2% between 2024 and 2034.

Semi-annual Industry Update

Country-wise Insights

Category-wise Insights

Find detailed analysis in Market Research Intellect's Diabetes Care Devices Market Report, estimated at USD 45.3 billion in 2024 and forecasted to climb to USD 75.5 billion by 2033, reflecting a CAGR of 6.8%.Stay informed about adoption trends, evolving technologies, and key market participants.

Diabetes Care Devices market witnessed USD 21,825.4 million in 2022 and is estimated to touch USD 33,750.0 million by 2030, growing at a CAGR of 5.6% till 2030

North America Diabetes Care Products comes with extensive industry analysis of development components, patterns, flows, and sizes. The report calculates present and past market values to forecast potential market management during the forecast period between 2025 - 2033.

The booming diabetes management products market is projected to reach $X Billion by 2033, driven by rising diabetes prevalence and technological advancements in CGM, insulin pumps, and digital health solutions. Learn about market trends, key players (Medtronic, Dexcom, Roche), and future growth opportunities in this comprehensive analysis.

The North America Diabetes Care Devices Market report segments the industry into Product (Monitoring Devices, Management Devices) and Geography (United States, Canada, Rest of North America). Get five years of historical data alongside five-year market forecasts.

Diabetes Care Devices Market Outlook

According to our latest research, the global Diabetes Care Devices market size reached USD 32.7 billion in 2024, reflecting robust demand across both developed and emerging economies. The market is expected to expand at a steady CAGR of 7.1% from 2025 to 2033, with the overall market projected to reach USD 60.7 billion by 2033. The growth of this market is primarily driven by the rising global prevalence of diabetes, technological advancements in glucose monitoring and insulin delivery, and increasing awareness regarding diabetes management and patient self-care.

The most significant growth factor for the diabetes care devices market is the alarming rise in diabetes incidence worldwide. A sedentary lifestyle, increasing obesity rates, and aging populations are contributing to a surge in both Type 1 and Type 2 diabetes cases. As a result, the demand for advanced blood glucose monitoring devices, continuous glucose monitoring systems, and innovative insulin delivery solutions is escalating. Furthermore, governments and healthcare organizations are launching various awareness campaigns and screening programs, which are boosting early diagnosis and, consequently, the adoption of diabetes care devices. The integration of digital health technologies and smartphone applications with diabetes care devices is also enhancing patient engagement and adherence, further fueling market growth.

Technological advancements play a pivotal role in shaping the diabetes care devices market landscape. Continuous innovations in glucose monitoring, such as the advent of minimally invasive and non-invasive monitoring systems, have significantly improved patient comfort and compliance. The introduction of smart insulin pens, closed-loop insulin delivery systems, and wearable continuous glucose monitors has revolutionized diabetes management, enabling real-time monitoring and precise insulin dosing. These advancements not only enhance patient outcomes but also reduce the burden of complications associated with poorly managed diabetes. Moreover, the integration of artificial intelligence and data analytics in diabetes care devices is empowering patients and healthcare professionals with actionable insights, fostering personalized treatment approaches.

The expansion of home-based diabetes care and the growing emphasis on patient-centric healthcare are also major contributors to market growth. With the increasing preference for self-monitoring and at-home care, there is a rising demand for user-friendly and portable diabetes care devices. This trend is further supported by the proliferation of online pharmacies and e-commerce platforms, making these devices more accessible to a broader patient population. Additionally, favorable reimbursement policies and the growing availability of diabetes care devices in retail and hospital pharmacies are facilitating market penetration, especially in emerging economies. As the focus on preventive healthcare intensifies, the adoption of diabetes care devices is expected to witness sustained momentum throughout the forecast period.

Regionally, North America dominates the diabetes care devices market, accounting for the largest share in 2024, followed by Europe and the Asia Pacific. The high prevalence of diabetes, advanced healthcare infrastructure, and strong presence of leading market players contribute to North America's market leadership. Meanwhile, the Asia Pacific region is poised for the fastest growth, driven by a rapidly increasing diabetic population, improving healthcare access, and rising awareness about diabetes management. Latin America and the Middle East & Africa are also witnessing steady growth, albeit from a smaller base, as healthcare investments and diabetes screening programs gain momentum in these regions.

Product Type Analysis

The diabetes care devices market is segmented by product type into blood glucose monitoring devices, insulin delivery devices, continuous glucose monitoring (CGM) systems, lancets, a

The global Diabetes Care Combination Products market is poised for substantial growth, projected to reach a market size of approximately $45,500 million by 2025. This expansion is driven by a Compound Annual Growth Rate (CAGR) of around 8.5% over the forecast period (2025-2033). The increasing prevalence of diabetes worldwide, coupled with a growing awareness among patients and healthcare providers regarding proactive management and combination therapies, is a primary catalyst. Advancements in product innovation, such as smart insulin pens, integrated continuous glucose monitoring (CGM) systems, and user-friendly insulin delivery devices, are further fueling market adoption. The shift towards personalized medicine and the demand for convenient, all-in-one solutions that simplify daily diabetes management are also significant contributors to this robust market trajectory. Key segments like Diabetes Testing Products and Insulin Pumps are expected to witness particularly strong demand, reflecting the ongoing need for accurate monitoring and efficient insulin delivery. The market dynamics are further shaped by a combination of supportive government initiatives aimed at managing chronic diseases, a rising disposable income in developing economies, and an aging global population, which is more susceptible to diabetes. However, certain factors may pose challenges to sustained growth. High product costs and the limited reimbursement policies in some regions could act as restraints. Additionally, the availability of alternative treatment modalities and the need for patient education to ensure proper usage of combination products will require strategic market approaches from key players. Despite these potential hurdles, the overarching trend points towards a continuously expanding market, with companies like Roche, Medtronic, and Abbott leading the charge through continuous innovation and strategic market penetration across diverse geographical regions. The focus on improving patient outcomes and quality of life in diabetes management will remain central to market expansion.

The size of the Brazil Diabetes Care Devices Market was valued at USD 1.06 Million in 2023 and is projected to reach USD XXX Million by 2032, with an expected CAGR of > 5.62% during the forecast period. Every diabetic patient should carry out proper regimen and proper management of the disease with the help of diabetes care technologies such as glucose meters, insulin pumps, and continuous glucose monitors. Technologies also help patients check their blood sugars, deliver insulin, and make proper decisions about their daily activities. This market in Brazil has grown immensely because of increased prevalence of diabetes and awareness toward the disease with modern technology. Because of the increase in such population and the increasing incidence rate of diabetes caused by unhealthy lifestyles, the need for efficient and new devices is increasing. A healthy Brazilian market is diversified with both global brands and companies that manufacture locally, ensuring that a wide portfolio of products reaches every corner to satisfy the needs of patients and healthcare providers alike. Recent developments include: October 2023: Molex, in collaboration with Phillips-Medisize and GlucoModicum, a Finnish medtech company, has joined forces to develop a cutting-edge continuous glucose monitor (CGM) that is non-invasive and does not require needles., August 2022: Abbott and WW International, Inc. (WeightWatchers) announced a strategic partnership to help people with diabetes better understand and manage their diabetes and weight. The companies are working to integrate WeightWatchers' diabetes-tailored weight management program with Abbott's portfolio of FreeStyle Libre products. They want to create a seamless mobile experience that will give people living with diabetes the information and insights needed to make healthy adjustments to their diet, improve their glucose levels, and, ultimately, gain more control of their health.. Key drivers for this market are: Rising Prevalence of Cancer Worldwide, Technological Advancements in Diagnostic Testing; Increasing Demand for Point-of-care Treatment. Potential restraints include: High Cost of Molecular Diagnostic Tests, Lack of Skilled Workforce and Stringent Regulatory Framework. Notable trends are: The continuous glucose monitoring segment is expected to witness a healthy growth rate over the forecast period.

The global Diabetes Management Devices market is poised for significant expansion, projected to reach approximately $43,190 million by 2025, exhibiting a robust Compound Annual Growth Rate (CAGR) of 7% through 2033. This growth is primarily fueled by the escalating prevalence of diabetes worldwide, driven by lifestyle changes, an aging population, and increased awareness regarding proactive health management. Technological advancements are also playing a pivotal role, with innovations in continuous glucose monitoring (CGM) systems and sophisticated insulin delivery devices offering greater accuracy, convenience, and personalized treatment. The increasing adoption of these advanced technologies by both healthcare providers and individuals with diabetes is a key driver, empowering patients to better manage their condition and reduce the risk of long-term complications. Furthermore, supportive government initiatives and growing reimbursement policies for diabetes care products are contributing to market accessibility and adoption, further stimulating market growth. The market is segmented into key applications, with Hospitals and Clinics representing the largest share due to the critical need for accurate monitoring and advanced treatment solutions in clinical settings. However, the "Others" segment, encompassing home-use devices and direct-to-consumer sales, is expected to witness substantial growth, driven by the increasing desire for convenience and self-management among individuals with diabetes. In terms of product types, Blood Glucose Monitoring Devices, including traditional meters and advanced CGMs, are dominant. Simultaneously, Insulin Delivery Systems, such as insulin pens and pumps, are experiencing a surge in demand as treatment modalities become more sophisticated and patient-centric. Geographically, North America and Europe currently lead the market, owing to well-established healthcare infrastructures and high adoption rates of advanced diabetes technologies. However, the Asia Pacific region is anticipated to emerge as the fastest-growing market, propelled by a large and growing diabetic population, increasing disposable incomes, and a rapidly evolving healthcare landscape. This report offers an in-depth analysis of the global Diabetes Management Devices market, encompassing a comprehensive study period from 2019 to 2033, with the Base Year and Estimated Year set for 2025, and a detailed Forecast Period from 2025 to 2033, building upon the Historical Period of 2019-2024. The market is poised for significant expansion, projected to reach [Insert Specific Value in Million Units based on report data] million units by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) throughout the forecast period.

Find detailed analysis in Market Research Intellect's Digital Diabetes Care Market Report, estimated at USD 7.25 billion in 2024 and forecasted to climb to USD 18.45 billion by 2033, reflecting a CAGR of 10.8%.Stay informed about adoption trends, evolving technologies, and key market participants.

Diabetes Care Devices Market Outlook

According to our latest research, the global diabetes care devices market size reached USD 29.4 billion in 2024, driven by a surge in diabetes prevalence and technological advancements in care solutions. The market is growing at a robust CAGR of 7.2% and is expected to reach USD 54.7 billion by 2033. This significant growth trajectory is fueled by increasing awareness about diabetes management, rising adoption of advanced monitoring and insulin delivery devices, and supportive government initiatives worldwide. The diabetes care devices market continues to evolve rapidly, offering innovative solutions that enhance patient outcomes and improve quality of life for millions globally.

The primary growth driver for the diabetes care devices market is the escalating prevalence of diabetes worldwide. According to the International Diabetes Federation, more than 537 million adults are living with diabetes as of 2024, and this number is projected to rise steadily in the coming years. The growing burden of both Type 1 and Type 2 diabetes is prompting healthcare providers and patients to seek more effective and convenient solutions for disease management. This trend has led to a surge in demand for blood glucose monitoring devices, insulin delivery systems, and continuous glucose monitoring devices, which are critical for maintaining optimal glycemic control and reducing the risk of diabetes-related complications. Furthermore, the increasing incidence of obesity, sedentary lifestyles, and unhealthy dietary habits are further exacerbating the diabetes epidemic, thereby driving the need for advanced diabetes care devices.

Technological innovation is another crucial factor propelling the diabetes care devices market forward. The integration of digital health technologies, such as mobile applications, cloud-based data management, and wearable sensors, has revolutionized diabetes care by enabling real-time monitoring, personalized feedback, and remote patient management. Continuous glucose monitors (CGMs) and smart insulin pens, for instance, offer patients and healthcare providers valuable insights into glucose trends and insulin usage patterns, facilitating more precise and proactive diabetes management. The development of minimally invasive and non-invasive devices, along with the advent of artificial intelligence and machine learning algorithms, is further enhancing the accuracy, convenience, and user experience of diabetes care solutions. These technological advancements are not only improving clinical outcomes but also increasing patient adherence and satisfaction, thereby contributing to the sustained growth of the diabetes care devices market.

Supportive government policies and reimbursement frameworks are also playing a pivotal role in the expansion of the diabetes care devices market. Many countries are implementing national diabetes prevention and management programs, investing in public health campaigns, and increasing funding for research and innovation in diabetes care. In addition, favorable reimbursement policies for advanced diabetes devices, particularly in developed markets such as North America and Europe, are making these products more accessible to a broader patient population. Collaborations between governments, healthcare organizations, and industry stakeholders are fostering the development and adoption of cost-effective and user-friendly diabetes care solutions. As healthcare systems worldwide prioritize chronic disease management and preventive care, the demand for reliable and efficient diabetes care devices is expected to remain strong in the foreseeable future.

From a regional perspective, North America currently dominates the diabetes care devices market, accounting for the largest share of global revenues. This leadership position is attributed to the high prevalence of diabetes, well-established healthcare infrastructure, and widespread adoption of advanced medical technologies in the region. Europe follows closely, with a strong focus on diabetes research, innovation, and patient education. Meanwhile, the Asia Pacific region is emerging as a lucrative market, driven by rapid urbanization, rising disposable incomes, and increasing awareness about diabetes management. Countries such as China and India are witnessing a surge in diabetes cases, prompting significant investments in healthcare infrastructure and diabetes care solutions. Latin America and the Middle East & Africa are also experiencing steady growth, albei

Market Research Intellect's Diabetes Care Products Market Report highlights a valuation of USD 58.5 billion in 2024 and anticipates growth to USD 85.0 billion by 2033, with a CAGR of 5.3% from 2026-2033.Explore insights on demand dynamics, innovation pipelines, and competitive landscapes.

Snapshot img

Diabetes Management Devices Market Size 2024-2028

The diabetes management devices market size is forecast to increase by USD 13.98 bn at a CAGR of 7.68% between 2023 and 2028.

The market is witnessing significant growth due to the rising global burden of diabetes and the increasing focus on advanced technologies such as artificial pancreas systems. These systems utilize insulin pumps and continuous glucose monitoring sensors to automatically adjust insulin delivery based on real-time glucose levels. Additionally, the integration of artificial intelligence and data analytics in diabetes management devices is revolutionizing the industry, enabling remote patient monitoring and personalized treatment plans. Other trends include the development of insulin pens with advanced features and the adoption of spectroscopy technology for non-invasive blood glucose monitoring. However, the prohibitive cost of diabetes care devices remains a major challenge for market growth.Overall, the market is expected to experience robust growth In the coming years, driven by technological advancements and the increasing prevalence of diabetes.

What will be the Size of the Diabetes Management Devices Market during the Forecast Period?

Request Free SampleThe market encompasses a range of technologies designed to assist individuals in managing their diabetes, including insulin delivery devices, mobile health applications, and disease management tools. With the global diabetic population projected to reach over 592 million by 2035, driven by factors such as obesity rates, smoking, and high cholesterol levels, the market for diabetes care devices is experiencing significant growth. Hospitals and specialty clinics are increasingly adopting minimally invasive devices, such as diabetes lancet devices and diabetes tracker devices, to improve patient care and outcomes. Type 1 diabetes, an autoimmune disease characterized by insulin deficiency, and Type 2 diabetes, often associated with insulin resistance, both require ongoing management to prevent complications, including kidney failure, gangrene, and lower limb amputation.Insulin delivery devices, including insulin pens and blood glucose level monitoring systems, are essential tools in managing both types of diabetes. The market for diabetes management devices is expected to continue expanding as technology advances and the global population ages.

How is this Diabetes Management Devices Industry segmented and which is the largest segment?

The diabetes management devices industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments. ProductBlood glucose monitoring devicesInsulin delivery systemsDistribution ChannelOfflineOnlineGeographyNorth AmericaUSEuropeGermanyUKFranceAsiaChinaRest of World (ROW)

By Product Insights

The blood glucose monitoring devices segment is estimated to witness significant growth during the forecast period. Diabetes management devices play a crucial role in monitoring and managing blood glucose levels for individuals with diabetes. These devices include a range of products such as insulin delivery systems, continuous monitoring systems, and glucose monitoring devices. Insulin delivery devices, including insulin pumps and pens, facilitate precise insulin administration. Continuous monitoring systems, such as continuous glucose monitoring systems (CGMs) and Mobi insulin pumps, provide real-time glucose level data through wireless transmission and dedicated apps. Glucowear, a continuous glucose monitoring system, offers non-invasive transdermal sensors and spectroscopy technology. Hospital pharmacies, retail pharmacies, and online pharmacies stock these diabetes care devices. The increasing prevalence of diabetes among the obese, elderly population, and those with conditions like high cholesterol levels, smoking, and inactive lifestyles necessitates effective diabetes management.Disease management is essential to prevent complications like kidney failure, gangrene, lower limb amputation, heart attack, blindness, and stroke. Diabetes tracker devices, such as diabetes monitoring software and artificial pancreas systems, help healthcare providers analyze glucose patterns and create treatment plans. User-friendly interfaces, visual representations, and medication adherence features enhance the efficacy of treatment. In summary, diabetes management devices, including insulin delivery devices, continuous monitoring systems, and glucose monitoring devices, are essential tools for managing diabetes and preventing complications. These devices offer precision, flexibility, and smart features, making diabetes care more accessible and convenient for individuals with diabetes. Hospital segment, diagnostic centers, diabetes clinics, and healthcare professionals uti

The Canada Diabetes Care Drugs and Devices Market is Segmented by Product Type (Devices [Monitoring Devices, and More] and Drugs [Insulin Drugs, and More]), Diabetes Type (Type 1 Diabetes and Type 2 Diabetes), Age Group (Adult, Geriatric, and More), and Distribution Channel (Offline and Online). The Market and Forecasts are Provided in Terms of Value (USD).

Learn more about the Diabetes Care Intelligence Center Market Report by Market Research Intellect, which stood at USD 12.5 billion in 2024 and is forecast to expand to USD 25 billion by 2033, growing at a CAGR of 9.5%.Discover how new strategies, rising investments, and top players are shaping the future.

Discover the booming diabetes care combination products market, projected to reach $45 billion by 2033. This in-depth analysis reveals key drivers, trends, restraints, and leading companies like Roche, Medtronic, and Abbott, shaping the future of diabetes management. Learn about market segmentation, CAGR, and regional insights.

Pet Diabetes Care Devices Sales Market Outlook

The global market size for Pet Diabetes Care Devices was valued at approximately USD 1.2 billion in 2023 and is projected to reach around USD 2.4 billion by 2032, reflecting a compound annual growth rate (CAGR) of 8.4%. The market's robust growth is primarily driven by increased pet ownership, rising awareness about pet health, and advances in veterinary technology. The growing prevalence of diabetes in pets, especially dogs and cats, necessitates the need for effective diabetes management solutions, fostering significant expansion in this sector.

One of the primary growth factors for the Pet Diabetes Care Devices market is the escalating prevalence of diabetes in pets. As pet ownership becomes more common and pets live longer lives due to better nutrition and healthcare, age-related diseases like diabetes are also on the rise. This scenario necessitates efficient diabetes care devices to monitor and manage pet health. Moreover, increasing awareness about pet health among pet owners is bolstering the demand for these devices. Owners are becoming more proactive in seeking medical care and preventive treatments for their pets, driving market growth substantially.

Technological advancements are another crucial factor propelling the market. Innovations in glucose monitoring devices and insulin delivery systems designed specifically for pets are transforming diabetes care. These advancements not only offer more accurate and reliable results but also enhance the ease of use for pet owners. For instance, continuous glucose monitoring systems that provide real-time data are gaining popularity. Additionally, user-friendly insulin delivery devices are reducing the complexities involved in pet diabetes management, thereby promoting their adoption across various end-users.

The expanding veterinary infrastructure globally is also significantly contributing to market growth. Veterinary clinics and hospitals are increasingly equipped with advanced diagnostic tools and treatment options, including diabetes care devices. This trend is particularly noticeable in urban areas where pet healthcare services are more accessible. Furthermore, the rising disposable income among pet owners allows them to spend more on advanced veterinary care, reinforcing the growth of the Pet Diabetes Care Devices market. The proliferation of pet insurance policies covering diabetes treatment is another factor positively impacting the market.

Product Type Analysis

The product type segment in the Pet Diabetes Care Devices market encompasses glucose monitoring devices, insulin delivery devices, and other related products. Glucose monitoring devices hold a significant share in this segment due to their necessity for regular blood sugar level checks. These devices are indispensable in managing diabetes effectively, making them highly sought after by both veterinary professionals and pet owners. Continuous glucose monitoring systems are particularly gaining traction as they offer continuous data, helping in better management of the condition.

Insulin delivery devices are another critical segment, including insulin pens, pumps, and syringes. With diabetes requiring lifelong management, the demand for reliable and easy-to-use insulin delivery devices is continually rising. Innovations in this segment, such as pre-filled pens and automated insulin pumps, are simplifying the administration process, thereby enhancing compliance among pet owners. The convenience offered by these advanced devices is driving their adoption in both homecare settings and veterinary clinics.

Other products in this segment include lancets, test strips, and diagnostic kits essential for the overall diabetes management ecosystem. These products, though smaller in size, play a crucial role in monitoring and managing diabetes effectively. The ease of availability and relatively lower cost of these products make them popular among pet owners and veterinarians alike. The increasing emphasis on comprehensive diabetes care is expected to keep the demand for these ancillary products robust over the forecast period.

Report Scope

The size of the Canada Diabetes Care Devices market was valued at USD XXX Million in 2023 and is projected to reach USD XXX Million by 2032, with an expected CAGR of 4.75% during the forecast period. Recent developments include: July 2023: Dexcom, Inc. has received approval from Health Canada for their latest Dexcom G7 Continuous Glucose Monitoring System. This advanced system is designed for individuals with diabetes of all types, aged two years and above. Dexcom, Inc. specializes in manufacturing reliable continuous glucose monitoring solutions for people living with diabetes., July 2022: NuGen Medical Devices Inc. announced that its needle-free injection system and accessories, also known as InsuJet, have been approved by Health Canada specifically for needle-free insulin delivery. While NuGen previously announced on December 9, 2021, that its needle-free injection system had received general use approval from Health Canada, the insulin-specific approval is the first ever insulin-specific needle-free system approved by Health Canada to sell into the healthcare system and its end users. This approval may also aid in obtaining coverage for the system by certain healthcare insurance providers in Canada.. Key drivers for this market are: , The Rise in Global Prevalence of Cases of Obesity due to Modern Sedentary Lifestyles; Rise in Awareness and Disposable Income in Developed Economies. Potential restraints include: , Highly Cost of Branded Products in Emerging Countries; Severe Adverse Associated with Medication Including Seizures, Suicidal Attempts and Even Death; Adoption of Traditional Yoga and Herbal Products. Notable trends are: The Continuous Glucose Monitoring Devices Segment is Growing at a Significant Pace.